LifePort kidney transporter: Portable donor kidney transporter/ perfuser

Mundy L, Hiller JE
Record ID 32010000763
English
Authors' recomendations: Machine perfusion for the preservation of kidneys for transplantation may not have statistically significant improved outcomes such as increased graft or patient survival when compared to conventional cold storage. However, improved graft function may lead to better patient quality of life and result in overall savings for the health system. More research is required to ascertain the most successful source of donor organs and to report on the long-term effects of the different methods of preservation. The LifePort device does offer portability which increases opportunities for organ exchange between states within Australia and between countries, such as Australia and New Zealand. The studies reported thus far have been a high level of evidence and it is unlikely that a higher level of evidence will be forthcoming in the near future. Jurisdictions are able to purchase this technology and will make purchasing decisions based on their needs. Therefore it is recommended that this summary be disseminated to specialists within the jurisdictions and that no further research is warranted.
Details
Project Status: Completed
Year Published: 2009
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Humans
  • Kidney Transplantation
  • Tissue and Organ Procurement
Contact
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name: ahta@adelaide.edu.au
Contact Email: ahta@adelaide.edu.au
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.